ATRC
AtriCure Inc
NASDAQ: ATRC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$40.89
+2.87% today
Updated 2026-07-29
Market cap
$1.77B
P/E ratio
—
P/S ratio
3.21x
EPS (TTM)
$-0.10
Dividend yield
—
52W range
$25 – $43
Volume
0.9M
AtriCure Inc (ATRC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$40.89
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$73.19
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.4B | $0.5B | $0.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -0.83%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.